Comparative Bioavailability and Effect of Food on CMX001 in Healthy Volunteers

Phase 1 Completed 24 enrolled Jazz Pharmaceuticals National Institutes of Health (NIH) · collab

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare the bioavailability of CMX001 when administered as a tablet vs a solution and to determine the effect of a high-fat meal on CMX001 bioavailability.

Timeline

Start: 2008-10
Primary completion: 2008-12
Completion: 2009-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Brincidofovir	Other / unclassified	40 mg	—

Indications

No indication recorded.